Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3.
Cancers (Basel). 2020 Oct 26;12(11):3127. doi: 10.3390/cancers12113127.
Cancers (Basel). 2020.
PMID: 33114555
Free PMC article.
Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib.
Büküm N, Novotná E, Morell A, Želazková J, Laštovičková L, Čermáková L, Portillo R, Solich P, Wsól V.
Büküm N, et al. Among authors: zelazkova j.
Biochem Pharmacol. 2021 Oct;192:114710. doi: 10.1016/j.bcp.2021.114710. Epub 2021 Jul 30.
Biochem Pharmacol. 2021.
PMID: 34339712
Item in Clipboard
SYNTHESIS AND AMINOPEPTIDASE N INHIBITING ACTIVITY OF 3-(NITROPHENOXYMETHYL)-[1,3,2]DIOXABOROLAN-2-OLS AND THEIR OPEN ANALOGUES.
Farsa O, Kana J, Macko I, Zelazkova J, Podlipna J, Cirkva A, Maxa J, Stastnv K.
Farsa O, et al. Among authors: zelazkova j.
Acta Pol Pharm. 2017 Jan;74(1):127-135.
Acta Pol Pharm. 2017.
PMID: 29474769
Free article.
Item in Clipboard
Cite
Cite